VivoSim Labs prices USD 4 million private placement at USD 0.85 per share

VivoSim Labs Inc

VivoSim Labs Inc

VIVS

0.00
  • VivoSim priced a $4 million private placement with a single healthcare-focused institutional investor at $0.85 per share and warrant.
  • Deal covers 4,705,883 common shares or equivalents, warrants for up to 4,705,883 shares at a $0.85 exercise price.
  • Warrants become exercisable after shareholder approval, expire five years from the initial exercise date.
  • 520,833 May 2024 warrants will be repriced to $0.85 from $9.60, subject to shareholder approval, with a five-year term.
  • Closing expected around July 17, 2026; proceeds earmarked for working capital and general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VivoSim Labs Inc. published the original content used to generate this news brief on July 16, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.